Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBS North Dakota Renal Ablation Policy | OpenPaye…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - North DakotaPolicy 235

    Radiofrequency and Ultrasound Ablation of the Renal Sympathetic Nerves as a Treatment for Uncontrolled Hypertension

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - North Dakota Policy 235 alerts

    Get alerted when Policy 235 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of percutaneous radiofrequency or ultrasound ablation of the renal sympathetic nerves for individuals with uncontrolled hypertension. The procedure may be medically necessary only when specified medication-resistance or medication-contraindication criteria are met; all other indications are investigational.

    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyRadiofrequency and Ultrasound Ablation of the Renal Sympathetic Nerves as a Treatment for Uncontrolled Hypertension
    Policy CodePolicy 235
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateJune 1, 2027
    Key ActionSubmit documentation identifying the classes of antihypertensive medications taken.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3+
    Medications required for one medical-necessity pathway
    3Medication classes required
    2Ablation modalities addressed
    InvestigationalOther indications or unmet criteria
    3Documentation categories required

    Medical Necessity and Investigational Status

    Medically Necessary

    Radiofrequency or ultrasound ablation of the renal sympathetic nerves may be considered medically necessary when either of the following pathways is met.

    At least one pathway

    • Medication-resistant hypertension

      • ALL of the following

        • The individual remains hypertensive despite use of three or more antihypertensive medications from three different classes at maximally tolerated doses.Three or more medications from three different classes at maximally tolerated doses

          Classes include angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, thiazide diuretics, and beta blockers.

    • Medication contraindications with uncontrolled blood pressure

      • ALL of the following

        • The individual has one or more contraindications to all classes of antihypertensive medications that prevent use of three different medication classes, and blood pressure remains uncontrolled despite lifestyle modifications.Contraindications to all classes; uncontrolled blood pressure despite lifestyle modifications

    Investigational

    Radiofrequency or ultrasound ablation of the renal sympathetic nerves is considered investigational when the following applies.

    Investigational use

    • The procedure is used for any indication other than the specified medically necessary pathways, or Criterion I is not met.

      All other indications and cases that do not meet the medical-necessity criteria are investigational.

    All other indications and cases in which the medical-necessity criteria are not met are considered investigational.

    Use of radiofrequency or ultrasound ablation of the renal sympathetic nerves for indications other than uncontrolled hypertension is considered investigational.

    Applicable Product and Procedure Codes

    FDA product codes referencedmixed
    DQYFDA product code associated with renal denervation devices
    QYIFDA product code for the Paradise Ultrasound Renal Denervation System
    CPT CodesCPT
    0338TTranscatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast injection(s), intraprocedural roadmapping and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram.
    0339TTranscatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast injection(s), intraprocedural roadmapping and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram and diagnostic renal angiography when performed; bilateral.
    Device CodeHCPCS
    C1736Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components.

    Documentation and Coverage Risk

    Documentation Required

    Submit History and Physical or Chart Notes

    Submit the individual’s history and physical examination or chart notes with the request so the clinical circumstances and uncontrolled hypertension can be evaluated against the policy criteria.

    Documentation Required

    Document Antihypertensive Medication Classes

    Document the classes of antihypertensive medications taken, including use of three or more classes at maximally tolerated doses when applicable.

    • Angiotensin-converting enzyme inhibitors
    • Angiotensin II receptor blockers
    • Calcium channel blockers
    • Thiazide diuretics
    • Beta blockers
    Documentation Required

    Procedure Overview

    Renal sympathetic nerve ablation is a percutaneous procedure performed through femoral arterial access. A catheter is advanced into the renal artery to deliver radiofrequency or ultrasound energy to the arterial walls where the renal sympathetic nerves are located.

    Policy Terms and Abbreviations

    Definition
    Uncontrolled hypertensionBlood pressure remains above targeted levels when an individual is not using or is unable to use treatments to control blood pressure, or when hypertension persists despite antihypertensive therapies.
    Definition
    Resistant hypertensionA form of uncontrolled hypertension in which blood pressure remains above the targeted range despite use of three or more antihypertensive medications, including a diuretic, with complementary mechanisms of action.
    Abbreviation
    RD/RDNRenal denervation.
    Abbreviation
    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyRadiofrequency and Ultrasound Ablation of the Renal Sympathetic Nerves as a Treatment for Uncontrolled Hypertension
    Policy CodePolicy 235
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateJune 1, 2027
    Key ActionSubmit documentation identifying the classes of antihypertensive medications taken.
    SourceLink
    On This Page
    Medical Necessity and Investigational StatusApplicable Product and Procedure CodesDocumentation and Coverage RiskProcedure OverviewPolicy Terms and Abbreviations

    Document Contraindications or Adverse Events

    Submit documentation of any contraindications or adverse events involving antihypertensive medication classes. If contraindications prevent use of three different classes, document the applicable contraindications and that blood pressure remains uncontrolled despite lifestyle modifications.

    • Identify the affected antihypertensive medication class or classes.
    • Describe the contraindication or adverse event and its clinical impact.
    • Document lifestyle modifications and persistent uncontrolled blood pressure when relying on contraindications.
    Denial Risk

    Investigational When Criteria Are Not Met

    Radiofrequency or ultrasound ablation of the renal sympathetic nerves is considered investigational for all other indications and when the medical-necessity criteria are not met.

    • Coverage may be denied when Criterion I is not met.
    • Coverage may be denied for indications other than uncontrolled hypertension.
    Denial Risk

    Insufficient Medication-Treatment History

    Coverage may be denied when the individual remains hypertensive despite documentation of fewer than three antihypertensive medication classes, unless contraindications to all classes prevent use of three different classes and the required uncontrolled blood pressure and lifestyle-modification documentation is provided.

    • Document three or more different antihypertensive classes at maximally tolerated doses when applicable.
    • If fewer than three classes were used, document contraindications to all classes that prevented use of three different classes.
    Denial Risk

    Criteria Not Met or Non-Hypertension Indication

    Use of radiofrequency or ultrasound ablation of the renal sympathetic nerves is considered investigational when policy criteria are not met or when the indication is other than uncontrolled hypertension, because sufficient research has not demonstrated improved net health outcomes in these circumstances.

    • Confirm the indication is uncontrolled hypertension.
    • Coverage is not supported when the policy criteria are not met or for a non-hypertension indication.
    rfRadiofrequency.
    Abbreviation
    AHTAntihypertensive therapy.
    Abbreviations
    SBP/DBPSystolic blood pressure and diastolic blood pressure.
    Abbreviations
    ASBP/ADBPAmbulatory systolic blood pressure and ambulatory diastolic blood pressure.
    Abbreviation
    MRAMain renal artery.
    Abbreviation
    usMRAUltrasound denervation of the main renal artery.
    Abbreviation
    CIConfidence interval; a range used to express the uncertainty around an estimated treatment effect.
    Abbreviation
    DBPDiastolic blood pressure.
    Abbreviation
    MDMean difference.
    Abbreviation
    NRNot reported.
    Abbreviation
    SBPSystolic blood pressure.
    Abbreviation
    RFARadiofrequency ablation.
    Abbreviation
    LOCFLast observation carried forward, a method used to impute missing follow-up measurements.
    Abbreviation
    MDMean difference; a measure of the average difference between treatment groups or from baseline.
    Abbreviation
    SBPSystolic blood pressure.
    Abbreviation
    SDStandard deviation; a measure of variability around the mean.